Depression can be treated in adults  effectively with psychotherapy. A new depression study has found out that talking therapy is as effective as the gold standard cognitive behavioural therapy.

The depression study used 440 adults with known depression cases from therapy services across three areas of England. Patients with depression were randomly assigned to a maximum of 20 sessions of behavioural activation treatment given by  junior mental health workers.The depression research on behavioural activation costed 20 percent less than people undergoing CBT, Livescience reported.

The most recent depression study have shown that behavioural activation therapy could be done by mental health workers and not just physicians. It also proved to be the longest and largest trials done on psychological treatment for depression.

According to David Richards, from the United Kingdom's University of Exeter, said that their findings challenge cognitive behavioural therapy efficacy for depression.   Behavioural activation has been set as the first line treatment for depression in the United Kingdom, according to Richards. Depression when treated with behavioural activation is believed to improve the access of worldwide psychological therapy, Science Daily reported.

The depression in adults was made the subject of study by researchers and they were able to find out that psychotherapy can be an inexpensive alternative to CBT in people suffering depression. The study also found out that talking therapies, specifically, is an effective alternative and one that does not have to wait long to get treated.

When the disease is treated with cognitive behavioural therapy, the treatment option can only delivered by physicians and trained specialists. When this is the case, people suffering from depression are limited to accessing cognitive behavioural therapy because they are unable to pay for the treatments. Other people with depression do not have access to health insurance.

Depression is a known mental health disorder suffered by 350 million people in the world. The study aims to render an effective treatment option to depression cases, especially those that do not have access to health insurances.